Mechanism of FTY720 on neural function improvement of rats with traumatic brain injury

doi:10.3877/cma.j.issn.1674-6880.2016.04.006

Abstract

Abstract:

Objective

To investigate the effect of FTY720 on neurological function in rats with traumatic brain injury and the related mechanism.

Methods

A total of 60 rats were randomly divided to the sham-operation group, model group and treatment group, 20 rats in each group. Modified Feeney free fall injury device was used to build rat craniocerebral injury model. Rats in the treatment group were administrated intraperitoneally with 1 mg/kg FTY720. Rats in the sham-operation group and model group were given 1 ml normal saline by intraperitoneal injection. After 24 hours, 10 rats in each group were sacrifice and their hippocampus tissues were used to determine the expression of nuclear factor-kappa B and microglial OX-42 by Western blotting and immunohistochemistry respectively. Additionally, the forelimb-placement test, balance test and modified neurological severity scores were used to assess the neurological function in each group.

Results

The expression of nuclear factor-kappa B (F=95.962, P<0.001) and microglial OX-42 (F=108.853, P<0.001) were all showed significant differences among the three groups, and were higher in the model group than those in the sham-operation group and treatment group (all P<0.05). Meanwhile, the forelimb-placement test [(7.0 ± 0.7) vs. (6.3 ± 0.5), (5.9 ± 0.7) vs. (5.0 ± 0.8), (4.9 ± 1.0) vs. (3.8 ± 0.8), (3.7 ± 1.1) vs. (2.3 ± 0.7); t=2.689, 2.586, 2.741, 3.525, P=0.015, 0.019, 0.013, 0.002], balance test [(4.3 ± 0.7) vs. (3.6 ± 0.7), (3.5 ± 1.1) vs. (2.6 ± 0.7), (2.9 ± 0.9) vs. (1.9 ± 0.7), (2.5 ± 0.7) vs. (1.8 ± 0.6); t=2.278, 2.212, 2.762, 2.333, P=0.035, 0.040, 0.013, 0.031] and modified neurological severity scores [(10.1 ± 1.0) vs. (8.7 ± 1.6), (8.8 ± 0.8) vs. (7.5 ± 1.5), (7.3 ± 1.0) vs. (5.6 ± 1.3), (5.7 ± 1.3) vs. (4.1 ± 1.4); t=2.385, 2.414, 3.400, 2.726, P=0.028, 0.027, 0.003, 0.014] on 7, 14, 21, 28 d after operation in the model group were higher as compared with the treatment group.

Conclusion

FTY720 could markedly improve the neurological function of rats with trauma brain injury and its mechanism might be related to the inhibition of FTY720 on central nervous system inflammation.

Key words: Craniocerebral trauma, Rat, FTY720, Neurological function

Jianyong Cai, Yan Wu, Huajun Ba, Chuan Lu, Xiandong Chen, Maohua Chen, Jun Sun. Mechanism of FTY720 on neural function improvement of rats with traumatic brain injury[J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2016, 09(04): 240-244.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhwzzyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-6880.2016.04.006

https://zhwzzyxzz.cma-cmc.com.cn/EN/Y2016/V09/I04/240

Figures/Tables 6

References 22

[1]	de Rivero Vaccari JC, Brand FJ 3rd, Berti AF, et al. Mincle signaling in the innate immune response after traumatic brain injury[J]. J Neurotrauma, 2015, 32 (4): 228-236.
[2]	Kelso ML, Gendelman HE. Bridge between neuroimmunity and traumatic brain injury[J]. Curr Pharm Des, 2014, 20 (26): 4284-4298.
[3]	李肖亮，单爱军，杜波，等.急危重症患者继发性脑损伤救治中脑保护的研究进展[J/CD].中华危重症医学杂志：电子版，2011，4（1）：47-52.
[4]	Brune K, Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs[J]. J Pain Res, 2015, 8 (1): 105-118.
[5]	Pitman MR, Woodcock JM, Lopez AF, et al. Molecular targets of FTY720 (fingolimod)[J]. Curr Mol Med, 2012, 12 (10): 1207-1219.
[6]	Patmanathan SN, Yap LF, Murray PG, et al. The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod[J]. J Cell Mol Med, 2015, 19 (10): 2329-2340.
[7]	Kawamata T, Dietrich WD, Schallert T, et al. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction[J]. Proc Natl Acad Sci USA, 1997, 94 (15): 8179-8184.
[8]	Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats[J]. Stroke, 2001, 32 (4): 1005-1011.
[9]	Zhang L, Wang HD, Ji XJ, et al. FTY720 for cancer therapy (review)[J]. Oncol Rep, 2013, 30 (6): 2571-2578.
[10]	Estella-Hermoso de Mendoza A, Castello-Cros R, Imbuluzqueta E, et al. Lipid nanosystems enhance the bioavailability and the therapeutic efficacy of FTY720 in acute myeloid leukemia[J]. J Biomed Nanotechnol, 2015, 11 (4): 691-701.
[11]	Yoshida Y, Tsuji T, Watanabe S, et al. Efficacy of combination treatment with fingolimod (FTY720) plus pathogenic autoantigen in a glucose-6-phosphate isomerase peptide (GPI325-339)-induced arthritis mouse model[J]. Biol Pharm Bull, 2013, 36 (11): 1739-1746.
[12]	Hinson HE, Rowell S, Schreiber M. Clinical evidence of inflammation driving secondary brain injury: A systematic review[J]. J Trauma Acute Care Surg,2015, 78 (1): 184-191.
[13]	Abdul-Muneer PM, Schuetz H, Wang F, et al. Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in animal model of mild traumatic brain injury induced by primary blast[J]. Free Radic Biol Med, 2013 (60): 282-291.
[14]	Dong XQ, Du Q, Yu WH, et al. Anti-inflammatory effects of oxymatrine through inhibition of nuclear factor-kappa B and mitogen-activated protein kinase activation in lipopolysaccharide-induced BV2 microglia cells[J]. Iran J Pharm Res, 2013, 12 (1): 165-174.
[15]	Ghosh M, Garcia-Castillo D, Aguirre V, et al. Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury[J]. Glia, 2012, 60 (12): 1839-1859.
[16]	Zhang W, Li B, Guo Y, et al. Rhamnetin attenuates cognitive deficit and inhibits hippocampal inflammatory response and oxidative stress in rats with traumatic brain injury[J]. Cent Eur J Immunol, 2015, 40 (1): 35-41.
[17]	Cui CM, Gao JL, Cui Y, et al. Chloroquine exerts neuroprotection following traumatic brain injury via suppression of inflammation and neuronal autophagic death[J]. Mol Med Rep, 2015, 12 (2): 2323-2328.
[18]	Janssen S, Schlegel C, Gudi V, et al. Effect of FTY720-phosphate on the expression of inflammation-associated molecules in astrocytes in vitro[J]. Mol Med Rep, 2015, 12 (4): 6171-6177.
[19]	Zhang Z, Zhang Z, Fauser U, et al. FTY720 attenuates accumulation of EMAP-Ⅱ+ and MHC-Ⅱ+ monocytes in early lesions of rat traumatic brain injury [J]. J Cell Mol Med, 2007, 11 (2): 307-314.
[20]	Rolland WB, Lekic T, Krafft PR, et al. Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage[J]. Exp Neurol, 2013 (1): 45-55.
[21]	Hasegawa Y, Suzuki H, Sozen T, et al. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats[J]. Stroke, 2010, 41 (2): 368-374.
[22]	Rolland WB 2nd, Manaenko A, Lekic T, et al. FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice[J]. Acta Neurochir Suppl, 2011 (111): 213-217.

Please choose a citation manager

Content to export